Menu
Recruiting NCT07749183

A Photoplethysmography-Based Machine Learning Algorithm for Early Atrial Fibrillation Detection: A Prospective Validation Study

Observational Atrial Fibrillation (AF) Heart Failure

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: PPG-based AF detection algorithm.
Who it may be relevant to
Registry conditions: Atrial Fibrillation (AF), Heart Failure. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Slovakia
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Prospective Validation of a Machine-Learning Algorithm Using Photoplethysmography Signals for Early Detection of Atrial Fibrillation During Remote Telemonitoring

Overview

This is a prospective study validating a new machine-learning algorithm that detects atrial fibrillation (AF) from photoplethysmography (PPG) signals, developed for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device, a CE-certified (Class IIb, MDR) device that monitors left ventricular filling pressures in heart failure patients. The algorithm will be validated through internal cross-validation, external validation against an independent cohort with paired PPG-ECG recordings, and validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions.

Detailed description

Atrial fibrillation (AF) and heart failure (HF) frequently coexist and share a bidirectional causal relationship; their concurrence is associated with worse clinical outcomes. Early detection of AF may enable timely intervention and improve outcomes. This study is prospectively validating a machine-learning algorithm for AF detection from PPG signals, intended for integration into the Seerlinq remote monitoring platform. This algorithm builds on the same core PPG signal-processing technology as Seerlinq's HeartCore device (a CE-certified, Class IIb device under the EU MDR that monitors left ventricular filling pressures in heart failure patients). It is a stand-alone algorithm designed specifically to detect clinically relevant (≥ 30s) atrial fibrillation.

Validation of the algorithm will proceed in three stages: (1) internal cross-validation; (2) external validation against an independent cohort with paired PPG-ECG recordings, to confirm generalizability; and (3) validation in a cohort of patients with paroxysmal atrial fibrillation and frequent sinus-AF transitions, to assess performance during clinically challenging rhythm changes.

The study is enrolling toward an estimated 1,000 unique PPG recordings. A 12-lead ECG is used to confirm cardiac rhythm classification (gold standard) as the reference for evaluating algorithm performance.

Interventions

  • Other PPG-based AF detection algorithm
    The PPG-based atrial fibrillation detection algorithm is a non-invasive signal processing approach that analyzes photoplethysmographic waveforms obtained during remote monitoring. The algorithm evaluates pulse-to-pulse variability, waveform characteristics, and signal quality parameters to identify irregular rhythm patterns associated with atrial fibrillation and provide early detection of potential arrhythmic events.

Primary outcome measures

  • Diagnostic accuracy (area under the ROC curve) of the PPG-based machine-learning algorithm for detecting clinically relevant AF (≥ 30s), compared with gold-standard 12-lead ECG [Time frame: Through study completion (estimated November 2026)]
Secondary outcome measures (8)
  • Sensitivity and specificity of the algorithm at the Youden-optimal threshold [Time frame: Through study completion (estimated November 2026)]
  • Positive predictive value and negative predictive value [Time frame: Through study completion (estimated November 2026)]
  • Average precision [Time frame: Through study completion (estimated November 2026)]
  • Model calibration [Time frame: Through study completion (estimated November 2026)]
  • Matthews correlation coefficient [Time frame: Through study completion (estimated November 2026)]
  • Overall classification accuracy [Time frame: Through study completion (estimated November 2026)]
  • Specificity and false-positive rate in the subgroup with frequent atrial/ventricular extrasystoles [Time frame: Through study completion (estimated November 2026)]
  • Accuracy of AF detection during sinus-AF transitions at the individual patient level [Time frame: Through study completion (estimated November 2026)]

Eligibility criteria

Inclusion criteria

  • Adults ≥18 years with a diagnosis of heart failure (HFrEF, HFmrEF, or HFpEF)
  • 12-lead ECG performed to confirm cardiac rhythm classification (AF vs. non-AF)

Exclusion criteria

  • Missing a valid PPG recording

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Slovakia · 1 center
  • Premedix — Bratislava

Identifiers

NCT: NCT07749183 · HeartCoreAF01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗